Resources
8 Results (showing 1 - 8)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 10/19/2020 (updated 3/29/2024)
The Providers Clinical Support System (PCSS) Mentoring Program support is recommended for clinicians who are contemplating or have recently begun prescribing MOUD and would like additional support. PCSS offers three tiers of service at no cost to the recipient: (1) a discussion forum, (2) the ability to submit a clinical question through the PCSS website, and (3) one-on-one mentoring.
Posted 10/7/2020 (updated 3/29/2024)
This toolkit contains clinical materials targeting treatment of substance use disorder in the acute care setting.
Posted 9/4/2020 (updated 3/29/2024)
Like all professions, the addictions treatment field is faced with the challenges of employee substance use and abuse and their impact on retention of quality staff. Because the addictions field employees a disproportionate number of individuals – by recent estimates close to half of the treatment workforce – in recovery, the field faces particular retention challenges. This toolkit provides meaningful and practical guidance to the problem of substance misuse among addictions professionals.
Posted 1/28/2020 (updated 3/28/2024)
Bridge (formerly CA Bridge) has training for care navigators, prescribers, and nurses. There is no cost for the trainings. You must create a free account to access the trainings.
Posted 5/11/2020 (updated 3/28/2024)
What to ask and what to look for after the initial diagnosis of HBsAg+
Posted 1/19/2024 (updated 3/28/2024)
The Peer Recovery Center of Excellence has developed a document to provide a brief overview of the role of peer specialist. It can help summarize the role of a peer specialist and how peer support can assist those in recovery.
Posted 1/17/2023 (updated 3/27/2024)
The Consolidated Appropriations Act of 2023 removed the federal requirement for providers to have an X-waiver to prescribe medications for the treatment of OUD. The act amended the Controlled Substances Act. Depending on state law, practitioners who have a current DEA registration with Schedule III authority will be able to prescribe buprenorphine for OUD starting now.
Posted 3/21/2022 (updated 3/27/2024)
NIDAMED’s mission is to develop science-based resources for health professionals and those in training about screening, addressing, and treating addiction.